Capital Impact Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History

Capital Impact Advisors, LLC

$3.16 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 23, 2023	SELL	$34.93 - $42.03 $233,751 - $281,264	-6,692 Reduced 30.02%	15,598 $565,000
Q3 2022 Nov 21, 2022	SELL	$28.79 - $35.41 $6,679 - $8,215	-232 Reduced 1.03%	22,290 $760,000
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $85,818 - $116,039	-3,388 Reduced 13.08%	22,522 $651,000
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $738,694 - $852,439	25,910 New	25,910 $837,000
Q4 2021 Feb 14, 2022	SELL	$26.37 - $34.22 $1.28 Million - $1.66 Million	-48,500 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$24.15 - $31.45 $1.17 Million - $1.53 Million	48,500 New	48,500 $1.27 Million
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $1.48 Million - $2.16 Million	-83,632 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.45 - $24.69 $72,264 - $123,474	5,001 Added 6.36%	83,632 $1.51 Million
Q4 2019 Feb 13, 2020	BUY	$19.93 - $29.13 $57,119 - $83,486	2,866 Added 3.78%	78,631 $1.87 Million
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $327,187 - $428,671	12,846 Added 20.42%	75,765 $2.08 Million
Q2 2019 Jul 19, 2019	BUY	$29.96 - $38.87 $546,889 - $709,532	18,254 Added 40.87%	62,919 $2.02 Million
Q4 2018 Mar 08, 2019	BUY	$30.84 - $49.51 $112,905 - $181,256	3,661 Added 8.93%	44,665 $1.45 Million
Q3 2018 Oct 19, 2018	BUY	$42.7 - $56.55 $138,305 - $183,165	3,239 Added 8.58%	41,004 $2.05 Million
Q2 2018 Jul 25, 2018	SELL	$44.1 - $59.85 $231,966 - $314,811	-5,260 Reduced 12.23%	37,765 $2.2 Million
Q1 2018 Apr 11, 2018	BUY	$37.15 - $46.9 $514,341 - $649,330	13,845 Added 47.45%	43,025 $1.97 Million
Q3 2017 Jan 16, 2018	BUY	$36.75 - $49.65 $1.07 Million - $1.45 Million	29,180	29,180 $1.17 Million

Others Institutions Holding SUPN

# of Institutions

286

Shares Held

60.7M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$416 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$245 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$204 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$115 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$105 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.14B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Account